FI945654A - Desferrioksamiini-B:n suolat ja niiden käyttö oraalisesti vaikuttavina rautakelaattoreina - Google Patents

Desferrioksamiini-B:n suolat ja niiden käyttö oraalisesti vaikuttavina rautakelaattoreina Download PDF

Info

Publication number
FI945654A
FI945654A FI945654A FI945654A FI945654A FI 945654 A FI945654 A FI 945654A FI 945654 A FI945654 A FI 945654A FI 945654 A FI945654 A FI 945654A FI 945654 A FI945654 A FI 945654A
Authority
FI
Finland
Prior art keywords
pct
desferrioxamine
salts
orally active
iron chelators
Prior art date
Application number
FI945654A
Other languages
English (en)
Swedish (sv)
Other versions
FI945654A0 (fi
Inventor
Nicholas Lowther
Ian Francis Hassan
Ian Timothy William Matthews
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI945654A publication Critical patent/FI945654A/fi
Publication of FI945654A0 publication Critical patent/FI945654A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI945654A 1992-06-03 1994-11-30 Desferrioksamiini-B:n suolat ja niiden käyttö oraalisesti vaikuttavina rautakelaattoreina FI945654A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929211779A GB9211779D0 (en) 1992-06-03 1992-06-03 Amine salts
PCT/GB1993/000940 WO1993024451A1 (en) 1992-06-03 1993-05-06 Desferrioxamine-b salts and their use as orally effective iron chelators

Publications (2)

Publication Number Publication Date
FI945654A true FI945654A (fi) 1994-11-30
FI945654A0 FI945654A0 (fi) 1994-11-30

Family

ID=10716488

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945654A FI945654A0 (fi) 1992-06-03 1994-11-30 Desferrioksamiini-B:n suolat ja niiden käyttö oraalisesti vaikuttavina rautakelaattoreina

Country Status (17)

Country Link
US (2) US5739167A (fi)
EP (1) EP0643690B1 (fi)
JP (1) JPH07507288A (fi)
KR (1) KR950701907A (fi)
AT (1) ATE166342T1 (fi)
AU (1) AU672607B2 (fi)
CA (1) CA2135394A1 (fi)
DE (1) DE69318711T2 (fi)
DK (1) DK0643690T3 (fi)
ES (1) ES2117132T3 (fi)
FI (1) FI945654A0 (fi)
GB (1) GB9211779D0 (fi)
HK (1) HK1009330A1 (fi)
NO (1) NO302749B1 (fi)
NZ (1) NZ252738A (fi)
TW (1) TW230203B (fi)
WO (1) WO1993024451A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE27799A1 (es) * 1996-12-10 1999-03-18 Novartis Ag Formulaciones y formas polimorficas de desferrioxamina y su preparacion
US7045531B1 (en) 1997-03-11 2006-05-16 The General Hospital Corporation Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
GB9727224D0 (en) * 1997-12-23 1998-02-25 Nycomed Imaging As Method
US6323218B1 (en) 1998-03-11 2001-11-27 The General Hospital Corporation Agents for use in the treatment of Alzheimer's disease
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
GB0117645D0 (en) * 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
US8236783B2 (en) * 2006-08-15 2012-08-07 Duke University ROS-sensitive iron chelators and methods of using the same
US9259670B2 (en) 2008-04-16 2016-02-16 The University Of Kentucky Research Foundation Flow-through filter to remove aluminum from medical solutions
US9139456B2 (en) 2008-04-16 2015-09-22 The Curators Of The University Of Missouri Chelating compounds and immobilized tethered chelators
US7932326B2 (en) * 2008-04-16 2011-04-26 The University Of Kentucky Research Foundation Chelating compounds and immobilized tethered chelators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH438351A (de) * 1959-09-25 1967-06-30 Ciba Geigy Verfahren zur Herstellung neuer Wuchsstoffe
FR1898M (fr) * 1961-04-07 1963-07-08 Ciba Geigy Nouvelle substance utilisable en thérapeutique.
US3679660A (en) * 1969-06-09 1972-07-25 Agatha C Magnus Glucosamine-alkylsulfonate and process
US3652411A (en) * 1969-12-04 1972-03-28 Mobil Oil Corp Polyglycol base lubricant
US4419365A (en) * 1981-12-21 1983-12-06 Ciba-Geigy Corporation Method of treating Alzheimer's disease
US4684482A (en) * 1984-01-26 1987-08-04 Oral-D (L.P.) Orally effective ion chelators
IT1173992B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
WO1992020227A1 (en) * 1991-05-13 1992-11-26 Oral-D Substituted orally effective ion chelators related to deferoxamine

Also Published As

Publication number Publication date
WO1993024451A1 (en) 1993-12-09
DK0643690T3 (da) 1999-01-25
NO302749B1 (no) 1998-04-20
AU672607B2 (en) 1996-10-10
EP0643690B1 (en) 1998-05-20
DE69318711D1 (de) 1998-06-25
KR950701907A (ko) 1995-05-17
NZ252738A (en) 1996-08-27
ES2117132T3 (es) 1998-08-01
CA2135394A1 (en) 1993-12-09
ATE166342T1 (de) 1998-06-15
AU4270093A (en) 1993-12-30
NO944617L (no) 1995-01-05
GB9211779D0 (en) 1992-07-15
TW230203B (fi) 1994-09-11
US5739167A (en) 1998-04-14
FI945654A0 (fi) 1994-11-30
US5663201A (en) 1997-09-02
JPH07507288A (ja) 1995-08-10
HK1009330A1 (en) 1999-05-28
NO944617D0 (no) 1994-12-01
DE69318711T2 (de) 1998-11-19
EP0643690A1 (en) 1995-03-22

Similar Documents

Publication Publication Date Title
PT88060A (pt) Processo para a preparacao de polietilenoglicol-carbaminatos
DK0697019T3 (da) Risperidon pamoater
CA2011294A1 (en) Carbonylation catalyst system
FI945654A (fi) Desferrioksamiini-B:n suolat ja niiden käyttö oraalisesti vaikuttavina rautakelaattoreina
ES2000185A6 (es) Procedimiento para preparar derivados de acidos piridoncaboxilicos
DE69332259D1 (de) Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung
GR1002573B (el) Μικροβιακη μεθοδος παρασκευης μεβινολινης.
ES8607218A1 (es) Un procedimiento para preparar compuestos de amidina
GB8530602D0 (en) Heterocyclic compounds
GB9206768D0 (en) New compounds for use in the treatment of cancer
ES8308864A1 (es) Procedimiento para la fabricacion de nuevos derivados aminoalcoxi aromaticos.
AU1951392A (en) Naphthylamine polycarboxylic acids
MX9804828A (es) Benzotiazolona etanaminas biologicamente activas.
ZA88446B (en) Allylmercaptoacetylsydnonimines,processes for their preparation, and their use
EP0306860A3 (en) 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof
ATE173471T1 (de) Pyridazinonderivate oder deren salze, verfahren zu ihrer herstellung und diese enthaltende antischockmittel
MY103910A (en) 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof
BR9406996A (pt) Enanciômero processo para preparar o mesmo processo para ciclizar um composto e composto intermediário
ZA929175B (en) 5,6-dihydro-dibenz(b,e)azepine-6,11-dione-11-oximes.
ES553600A0 (es) Un procedimiento para la preparacion de nuevos derivados de diamina.
ATE77744T1 (de) Verwendung von pyrrothinderivaten.
NO954410L (no) Fremgangsmåte og fremstilling av NG-monoalkyl-L-arginin og beslektede forbindelser
ES8703421A1 (es) Procedimiento para preparar derivados de pirrolidindiona.
ES8500620A1 (es) Procedimiento para la preparacion de derivados e-homo-eburnanos racemicos u opticamente activos y de sus sales de adicion acidas.
NO932251L (no) Chelaterende forbindelser

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG